publication date: Nov. 10, 2017

In Brief WUSTL’s DiPersio receives $6 million for leukemia research

John DiPersio, of Washington University School of Medicine in St. Louis, received a $6 million outstanding investigator award from NCI to support research aimed at improving therapies for leukemia.

DiPersio, the Virginia E. and Sam J. Golman Professor of Medicine in Oncology, is also deputy director of Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine and director of the Division of Oncology at the School of Medicine. He was the founding director of the adult bone marrow and stem cell transplant program.

“One of our major goals is to optimize stem cell transplantation—both in making the process of donating stem cells faster and more efficient and in finding ways to control the potentially damaging side effects of the transplant,” DiPersio said.

The NCI grant will support three major areas of research in DiPersio’s lab:

Improving the effectiveness of standard chemotherapy and making stem cell donation faster and more efficient. DiPersio and Michael Rettig, an associate professor of medicine, are seeking better ways to force cancerous cells to move out of bone marrow and into the bloodstream, where they are more vulnerable to chemotherapy. Boosting this movement of blood stem cells also helps speed the process of harvesting healthy stem cells from a donor, … Continue reading WUSTL’s DiPersio receives $6 million for leukemia research

To access this members-only content, please log in.
If you're not a subscriber why not join today?
If you believe you should be able to view this area but cannot log in, then please contact us and we will try to rectify this issue as soon as possible.
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2018 The Cancer Letter Inc.